Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Addiction. 2023 May 22;118(10):1942–1952. doi: 10.1111/add.16229

TABLE 1.

Summary of MTAG results.

EUR
AFR
OUD
CUD
AUD
SMK
OUD
AUD
SMK
GWAS MTAG GWAS MTAG GWAS MTAG GWAS MTAG GWAS MTAG GWAS MTAG GWAS MTAG

SNPs used for MTAG 2 888 846 2 888 846 2 888 846 2 888 846 2 648 505 2 648 505 2 648 505
SigSNPs 18 1465 7 2547 363 1854 3049 5380 3 7 59 45 0 3
SigSNPs (after clumping) 4 41 2 74 20 63 105 183 1 2 4 3 0 1
Independent locus 4 36 2 60 12 52 74 144 1 2 2 2 0 1
χ2 1.159 1.376 1.099 1.455 1.281 1.463 1.771 1.865 1.021 1.045 1.053 1.055 1.044 1.049
Effective sample size 74 635 176 876 48 900 223 956 171 601 282 208 632 802 709 603 32 240 68 047 67 686 71 092 40 736 45 743

Abbreviations: AFR, African ancestry; AUD, alcohol use disorder; CUD, cannabis use disorder; EUR, European ancestry; GWAS, genome-wide association studies; OUD, opioid use disorder; MTAG, multi-trait analysis of GWAS; SMK, smoking; SNPs, single nucleotide polymorphisms, SigSNPs, SNPs that reach a genome wide significant p-value threshold < 5 × 10−8.